On the contrary, PIK3CA mutation favors malignant progression in head and neck squamous cell carcinoma [16], and poor prognosis in ovarian cancer [17], whereas PIK3CA amplification predicts reduced survival in gastric cancer [18]. Here, PIK3CA is linked to ovarian cancer.